Value of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation in treating drug-resistant focal epilepsy. Issue 3 (September 2019)

• Record Type: Journal Article
• Authors: Bai, Jianjun; Zhou, Wenjing; Wang, Haixiang; Zhang, Bingqing; Lin, Jiuluan; Song, Xiancheng; Li, Jia; Ruan, Jing; Liu, Yiou; Shi, Jie; He, Jing; Feng, Qian
• Is Part Of: Brain science advances. Volume 5:Issue 3(2019)
• Page Start: 189
• Page End: 202
• Publication Date: 2019-09
• Subjects: epilepsy -- radiofrequency thermocoagulation -- stereoelectroencephalography; Neurosciences -- Periodicals; Medical innovations -- Periodicals; Medical innovations; Neurosciences; Periodicals; 616.8005
• DOI: 10.26599/BSA.2019.9050015
• Languages: English
• ISSNs: 2096-5958

Abstract

Stereoelectroencephalography (SEEG) has been widely used in the presurgical evaluation of patients with medically intractable epilepsy. In the past, SEEG was commonly used as a method for mapping and localizing the epileptogenic zone (EZ). Since 2004, several studies have been conducted to examine the effectiveness of SEEG-guided radiofrequency thermocoagulation (RF-TC) in treating refractory epilepsy. However, the seizure-free and responder rates varied greatly across studies. We aimed to analyze the outcome of 56 patients who were treated with SEEG-guided RF-TC to evaluate the effectiveness of this treatment. SEEG-guided RF-TC can be considered as a treatment for refractory epilepsy. However, due to its limited efficacy, SEEG-guided RF-TC might be regarded as a temporary treatment performed under SEEG rather than a promising treatment for refractory epilepsy.